0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Varicella Vaccine Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-37D11956
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Varicella Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Varicella Vaccine Market Research Report 2024

Code: QYRE-Auto-37D11956
Report
February 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Varicella Vaccine Market Size

The global Varicella Vaccine market was valued at US$ 4174 million in 2023 and is anticipated to reach US$ 7104.7 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.

Varicella Vaccine Market

Varicella Vaccine Market

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
This report aims to provide a comprehensive presentation of the global market for Varicella Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Varicella Vaccine.

Report Scope

The Varicella Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Varicella Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Varicella Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Varicella Vaccine Market Report

Report Metric Details
Report Name Varicella Vaccine Market
Accounted market size in 2023 US$ 4174 million
Forecasted market size in 2030 US$ 7104.7 million
CAGR 7.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Injection
  • Freeze-Dried Powder
Segment by Application
  • Kids Injection
  • Adults Injection
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Varicella Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Varicella Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Varicella Vaccine Market growing?

Ans: The Varicella Vaccine Market witnessing a CAGR of 7.8% during the forecast period 2024-2030.

What is the Varicella Vaccine Market size in 2030?

Ans: The Varicella Vaccine Market size in 2030 will be US$ 7104.7 million.

What is the Varicella Vaccine Market share by type?

Ans: In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%.

Who are the main players in the Varicella Vaccine Market report?

Ans: The main players in the Varicella Vaccine Market are Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken

What are the Application segmentation covered in the Varicella Vaccine Market report?

Ans: The Applications covered in the Varicella Vaccine Market report are Kids Injection, Adults Injection

What are the Type segmentation covered in the Varicella Vaccine Market report?

Ans: The Types covered in the Varicella Vaccine Market report are Injection, Freeze-Dried Powder

1 Varicella Vaccine Market Overview
1.1 Product Overview and Scope of Varicella Vaccine
1.2 Varicella Vaccine Segment by Type
1.2.1 Global Varicella Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Varicella Vaccine Segment by Application
1.3.1 Global Varicella Vaccine Market Value by Application: (2024-2030)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Global Varicella Vaccine Market Size Estimates and Forecasts
1.4.1 Global Varicella Vaccine Revenue 2019-2030
1.4.2 Global Varicella Vaccine Sales 2019-2030
1.4.3 Global Varicella Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Varicella Vaccine Market Competition by Manufacturers
2.1 Global Varicella Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Varicella Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Varicella Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Varicella Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Varicella Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Varicella Vaccine, Product Type & Application
2.7 Varicella Vaccine Market Competitive Situation and Trends
2.7.1 Varicella Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Varicella Vaccine Players Market Share by Revenue
2.7.3 Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Varicella Vaccine Retrospective Market Scenario by Region
3.1 Global Varicella Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Varicella Vaccine Global Varicella Vaccine Sales by Region: 2019-2030
3.2.1 Global Varicella Vaccine Sales by Region: 2019-2024
3.2.2 Global Varicella Vaccine Sales by Region: 2025-2030
3.3 Global Varicella Vaccine Global Varicella Vaccine Revenue by Region: 2019-2030
3.3.1 Global Varicella Vaccine Revenue by Region: 2019-2024
3.3.2 Global Varicella Vaccine Revenue by Region: 2025-2030
3.4 North America Varicella Vaccine Market Facts & Figures by Country
3.4.1 North America Varicella Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Varicella Vaccine Sales by Country (2019-2030)
3.4.3 North America Varicella Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Varicella Vaccine Market Facts & Figures by Country
3.5.1 Europe Varicella Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Varicella Vaccine Sales by Country (2019-2030)
3.5.3 Europe Varicella Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Varicella Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Varicella Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Varicella Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Varicella Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Varicella Vaccine Market Facts & Figures by Country
3.7.1 Latin America Varicella Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Varicella Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Varicella Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Varicella Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Varicella Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Varicella Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Varicella Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Varicella Vaccine Sales by Type (2019-2030)
4.1.1 Global Varicella Vaccine Sales by Type (2019-2024)
4.1.2 Global Varicella Vaccine Sales by Type (2025-2030)
4.1.3 Global Varicella Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Varicella Vaccine Revenue by Type (2019-2030)
4.2.1 Global Varicella Vaccine Revenue by Type (2019-2024)
4.2.2 Global Varicella Vaccine Revenue by Type (2025-2030)
4.2.3 Global Varicella Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Varicella Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Varicella Vaccine Sales by Application (2019-2030)
5.1.1 Global Varicella Vaccine Sales by Application (2019-2024)
5.1.2 Global Varicella Vaccine Sales by Application (2025-2030)
5.1.3 Global Varicella Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Varicella Vaccine Revenue by Application (2019-2030)
5.2.1 Global Varicella Vaccine Revenue by Application (2019-2024)
5.2.2 Global Varicella Vaccine Revenue by Application (2025-2030)
5.2.3 Global Varicella Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Varicella Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Varicella Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Varicella Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Shanghai Institute
6.3.1 Shanghai Institute Corporation Information
6.3.2 Shanghai Institute Description and Business Overview
6.3.3 Shanghai Institute Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shanghai Institute Varicella Vaccine Product Portfolio
6.3.5 Shanghai Institute Recent Developments/Updates
6.4 BCHT
6.4.1 BCHT Corporation Information
6.4.2 BCHT Description and Business Overview
6.4.3 BCHT Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BCHT Varicella Vaccine Product Portfolio
6.4.5 BCHT Recent Developments/Updates
6.5 Changsheng
6.5.1 Changsheng Corporation Information
6.5.2 Changsheng Description and Business Overview
6.5.3 Changsheng Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Changsheng Varicella Vaccine Product Portfolio
6.5.5 Changsheng Recent Developments/Updates
6.6 Keygen
6.6.1 Keygen Corporation Information
6.6.2 Keygen Description and Business Overview
6.6.3 Keygen Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Keygen Varicella Vaccine Product Portfolio
6.6.5 Keygen Recent Developments/Updates
6.7 Green Cross
6.6.1 Green Cross Corporation Information
6.6.2 Green Cross Description and Business Overview
6.6.3 Green Cross Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Green Cross Varicella Vaccine Product Portfolio
6.7.5 Green Cross Recent Developments/Updates
6.8 Biken
6.8.1 Biken Corporation Information
6.8.2 Biken Description and Business Overview
6.8.3 Biken Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biken Varicella Vaccine Product Portfolio
6.8.5 Biken Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Varicella Vaccine Industry Chain Analysis
7.2 Varicella Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Varicella Vaccine Production Mode & Process
7.4 Varicella Vaccine Sales and Marketing
7.4.1 Varicella Vaccine Sales Channels
7.4.2 Varicella Vaccine Distributors
7.5 Varicella Vaccine Customers
8 Varicella Vaccine Market Dynamics
8.1 Varicella Vaccine Industry Trends
8.2 Varicella Vaccine Market Drivers
8.3 Varicella Vaccine Market Challenges
8.4 Varicella Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Varicella Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Varicella Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Varicella Vaccine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Varicella Vaccine Sales (M Doses) of Key Manufacturers (2019-2024)
    Table 5. Global Varicella Vaccine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Varicella Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Varicella Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Varicella Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Varicella Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Varicella Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Varicella Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Varicella Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Varicella Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Varicella Vaccine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Varicella Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Varicella Vaccine Sales by Region (2019-2024) & (M Doses)
    Table 18. Global Varicella Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Varicella Vaccine Sales by Region (2025-2030) & (M Doses)
    Table 20. Global Varicella Vaccine Sales Market Share by Region (2025-2030)
    Table 21. Global Varicella Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Varicella Vaccine Revenue Market Share by Region (2019-2024)
    Table 23. Global Varicella Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Varicella Vaccine Revenue Market Share by Region (2025-2030)
    Table 25. North America Varicella Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 27. North America Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 28. North America Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Varicella Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 32. Europe Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 33. Europe Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Varicella Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Varicella Vaccine Sales by Region (2019-2024) & (M Doses)
    Table 37. Asia Pacific Varicella Vaccine Sales by Region (2025-2030) & (M Doses)
    Table 38. Asia Pacific Varicella Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Varicella Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Varicella Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 42. Latin America Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 43. Latin America Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Varicella Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 47. Middle East & Africa Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 48. Middle East & Africa Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Varicella Vaccine Sales (M Doses) by Type (2019-2024)
    Table 51. Global Varicella Vaccine Sales (M Doses) by Type (2025-2030)
    Table 52. Global Varicella Vaccine Sales Market Share by Type (2019-2024)
    Table 53. Global Varicella Vaccine Sales Market Share by Type (2025-2030)
    Table 54. Global Varicella Vaccine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Varicella Vaccine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Varicella Vaccine Revenue Market Share by Type (2019-2024)
    Table 57. Global Varicella Vaccine Revenue Market Share by Type (2025-2030)
    Table 58. Global Varicella Vaccine Price (USD/Dose) by Type (2019-2024)
    Table 59. Global Varicella Vaccine Price (USD/Dose) by Type (2025-2030)
    Table 60. Global Varicella Vaccine Sales (M Doses) by Application (2019-2024)
    Table 61. Global Varicella Vaccine Sales (M Doses) by Application (2025-2030)
    Table 62. Global Varicella Vaccine Sales Market Share by Application (2019-2024)
    Table 63. Global Varicella Vaccine Sales Market Share by Application (2025-2030)
    Table 64. Global Varicella Vaccine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Varicella Vaccine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Varicella Vaccine Revenue Market Share by Application (2019-2024)
    Table 67. Global Varicella Vaccine Revenue Market Share by Application (2025-2030)
    Table 68. Global Varicella Vaccine Price (USD/Dose) by Application (2019-2024)
    Table 69. Global Varicella Vaccine Price (USD/Dose) by Application (2025-2030)
    Table 70. Merck Corporation Information
    Table 71. Merck Description and Business Overview
    Table 72. Merck Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 73. Merck Varicella Vaccine Product
    Table 74. Merck Recent Developments/Updates
    Table 75. GSK Corporation Information
    Table 76. GSK Description and Business Overview
    Table 77. GSK Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 78. GSK Varicella Vaccine Product
    Table 79. GSK Recent Developments/Updates
    Table 80. Shanghai Institute Corporation Information
    Table 81. Shanghai Institute Description and Business Overview
    Table 82. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 83. Shanghai Institute Varicella Vaccine Product
    Table 84. Shanghai Institute Recent Developments/Updates
    Table 85. BCHT Corporation Information
    Table 86. BCHT Description and Business Overview
    Table 87. BCHT Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 88. BCHT Varicella Vaccine Product
    Table 89. BCHT Recent Developments/Updates
    Table 90. Changsheng Corporation Information
    Table 91. Changsheng Description and Business Overview
    Table 92. Changsheng Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 93. Changsheng Varicella Vaccine Product
    Table 94. Changsheng Recent Developments/Updates
    Table 95. Keygen Corporation Information
    Table 96. Keygen Description and Business Overview
    Table 97. Keygen Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 98. Keygen Varicella Vaccine Product
    Table 99. Keygen Recent Developments/Updates
    Table 100. Green Cross Corporation Information
    Table 101. Green Cross Description and Business Overview
    Table 102. Green Cross Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 103. Green Cross Varicella Vaccine Product
    Table 104. Green Cross Recent Developments/Updates
    Table 105. Biken Corporation Information
    Table 106. Biken Description and Business Overview
    Table 107. Biken Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 108. Biken Varicella Vaccine Product
    Table 109. Biken Recent Developments/Updates
    Table 110. Key Raw Materials Lists
    Table 111. Raw Materials Key Suppliers Lists
    Table 112. Varicella Vaccine Distributors List
    Table 113. Varicella Vaccine Customers List
    Table 114. Varicella Vaccine Market Trends
    Table 115. Varicella Vaccine Market Drivers
    Table 116. Varicella Vaccine Market Challenges
    Table 117. Varicella Vaccine Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Varicella Vaccine
    Figure 2. Global Varicella Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Varicella Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Injection Product Picture
    Figure 5. Freeze-Dried Powder Product Picture
    Figure 6. Global Varicella Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Varicella Vaccine Market Share by Application in 2023 & 2030
    Figure 8. Kids Injection
    Figure 9. Adults Injection
    Figure 10. Global Varicella Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Varicella Vaccine Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Varicella Vaccine Sales (2019-2030) & (M Doses)
    Figure 13. Global Varicella Vaccine Average Price (USD/Dose) & (2019-2030)
    Figure 14. Varicella Vaccine Report Years Considered
    Figure 15. Varicella Vaccine Sales Share by Manufacturers in 2023
    Figure 16. Global Varicella Vaccine Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Varicella Vaccine Players: Market Share by Revenue in 2023
    Figure 18. Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Varicella Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Varicella Vaccine Sales Market Share by Country (2019-2030)
    Figure 21. North America Varicella Vaccine Revenue Market Share by Country (2019-2030)
    Figure 22. U.S. Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Varicella Vaccine Sales Market Share by Country (2019-2030)
    Figure 25. Europe Varicella Vaccine Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Varicella Vaccine Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Varicella Vaccine Revenue Market Share by Region (2019-2030)
    Figure 33. China Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Varicella Vaccine Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Varicella Vaccine Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Varicella Vaccine Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Varicella Vaccine Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Varicella Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Varicella Vaccine by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Varicella Vaccine by Type (2019-2030)
    Figure 54. Global Varicella Vaccine Price (USD/Dose) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Varicella Vaccine by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Varicella Vaccine by Application (2019-2030)
    Figure 57. Global Varicella Vaccine Price (USD/Dose) by Application (2019-2030)
    Figure 58. Varicella Vaccine Value Chain
    Figure 59. Varicella Vaccine Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS